CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 40 (12) 1323-34
Year:
2022
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Long-Term-Followup
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
11
Parents:
2151   2371   2539   3079   3139   3392  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Genentech  
Grants:
U10CA180821, U10CA180882, U24CA196171, UG1CA189858, UG1CA233180, UG1CA233253, UG1CA233290, UG1CA233327, UG1CA233339, UG1CA233373, P30CA033572, P50CA58223, U10CA180888 (SWOG)  
Corr. Author:
 
Authors:
                                                               
Networks:
CA043, KAISER, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, NY021, RI005, SCOR   
Study
CALGB-40603
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: